Retatrutide Price: Compounded Pricing & Cost Comparison Guide
Understand current retatrutide pricing, calculate cost per mg, compare bulk discounts, and see how pricing stacks against semaglutide and tirzepatide.
Current Retatrutide Compounded Pricing (2026)
Retatrutide pricing in the compounded market reflects the early-stage nature of the peptide and ongoing clinical trial exclusivity. As of March 2026, compounded retatrutide ranges from $400 to $700 per 10mg vial from reputable, licensed compounding pharmacies. This variance depends on several factors: vial concentration, third-party testing certifications, batch size, and the compounder\'s operational overhead.
Standard Pricing Tiers
| Vial Size | Standard Price Range | Cost per mg | Certification Level |
|---|---|---|---|
| 5mg vial | $300-$425 | $60-$85/mg | Basic to USP 797 |
| 10mg vial | $400-$700 | $40-$70/mg | Standard to Full USP 797 + COA |
| 15mg vial | $550-$900 | $37-$60/mg | Full USP 797 + Third-party testing |
The 10mg vial offers the best balance between cost-per-mg and practical vial size. Smaller 5mg vials cost more per mg due to fixed manufacturing and testing costs being spread across less material. Larger 15mg vials reduce per-mg costs but require reliable storage and longer usage timelines.
Monthly Cost Breakdown: What You\'ll Actually Spend
Your monthly retatrutide cost depends on your current dose in the titration schedule. Most users spend the first 4 weeks at 1mg, then escalate every 4 weeks. Let\'s break down realistic monthly costs.
Cost by Titration Phase
| Dose Phase | Weekly Dose | Monthly Usage | Monthly Cost (at $50/mg) | Typical Vial Purchase |
|---|---|---|---|---|
| 1mg (Weeks 1-4) | 1mg/week | 4mg/month | $200 | One 10mg vial (~$500) |
| 4mg (Weeks 5-8) | 4mg/week | 16mg/month | $800 | Two 10mg vials (~$1,000) |
| 8mg (Weeks 9-12) | 8mg/week | 32mg/month | $1,600 | Three 10mg vials (~$1,500) |
| 12mg (Week 13+) Maintenance | 12mg/week | 48mg/month | $2,400 | Five 10mg vials (~$2,500) |
Your first month is typically the least expensive (primarily 1mg dosing), with costs escalating as you reach higher doses. By month 4 and beyond, when at the 12mg maintenance dose, expect $2,000-$3,000 monthly depending on your compounder\'s pricing. Many users front-load purchases at the 1mg phase to build inventory for later escalation.
Bulk & Subscription Pricing Discounts
Most reputable compounders offer volume discounts and subscription models that reduce per-vial costs. Understanding these discounts can save hundreds monthly.
Bulk Discount Structures
- Single vial: Full price ($400-$700 per 10mg vial)
- 2 vials: 5-10% discount per vial ($360-$665 per vial)
- 3-4 vials: 10-15% discount per vial ($340-$595 per vial)
- 5+ vials: 15-25% discount per vial ($300-$595 per vial)
- Monthly subscription: Auto-ship 10-15% discount, cancellable anytime
Strategic Purchasing to Maximize Savings
Savvy users approach purchasing strategically. During the lower-dose phases (1mg and 4mg weeks), vial inventory grows slowly. Many users purchase 3-4 vials during early phases when bulk discounts apply, building inventory for later escalation. This approach reduces average per-mg cost across the entire titration period.
Example strategy: Purchase three 10mg vials in week 1 at bulk pricing ($1,350 total = $45/mg), then spread usage across months 1-4 while taking advantage of the discount.
Price Comparison: Retatrutide vs Tirzepatide vs Semaglutide
How does retatrutide pricing compare to other GLP-1 and dual-action agonists in the compounded market? The comparison reveals interesting economics and value propositions.
Per-Vial & Per-Milligram Pricing Comparison
| Peptide | Standard Vial | Typical Price | Cost per mg | Potency |
|---|---|---|---|---|
| Semaglutide | 5mg vial | $300-$500 | $60-$100/mg | Single GLP-1 agonist |
| Tirzepatide | 10mg vial | $350-$600 | $35-$60/mg | GLP-1+GIP dual agonist |
| Retatrutide | 10mg vial | $400-$700 | $40-$70/mg | GLP-1+GIP+Glucagon triple agonist |
Value Analysis: Cost vs Efficacy
On a per-mg basis, tirzepatide is the most affordable ($35-$60/mg), retatrutide is mid-range ($40-$70/mg), and semaglutide is the most expensive ($60-$100/mg). However, efficacy per dollar spent tells a different story:
- Semaglutide: 15% average body weight loss; approximately $333-$667 per 1% weight loss
- Tirzepatide: 20% average body weight loss; approximately $175-$300 per 1% weight loss
- Retatrutide: 24.2% average body weight loss; approximately $165-$289 per 1% weight loss
Despite slightly higher per-mg costs, retatrutide offers superior cost-to-efficacy ratio due to its greater weight loss results. For users primarily motivated by weight loss outcomes, retatrutide provides better value than semaglutide.
International Pricing Variations
Retatrutide pricing varies significantly by country due to import regulations, pharmaceutical pricing standards, and local compounding licensing. Understanding international pricing is important for users considering cross-border purchasing.
Typical Global Pricing
- United States: $400-$700 per 10mg vial (fully compounded)
- Canada: CAD $500-$900 per 10mg vial (limited availability)
- Mexico: MXN $6,000-$12,000 per 10mg vial (~USD $350-$700)
- European Union: EUR 450-$850 per 10mg vial (regulatory restricted)
- Australia/New Zealand: Limited availability; prices 15-20% higher than US when available
Cross-Border Purchasing Considerations
While international pricing may appear cheaper, several risks offset savings: import duties and customs taxes (5-15% in most countries), shipping costs ($30-$100), longer delivery times (2-3 weeks), and regulatory compliance issues. Many countries restrict importing pharmaceutical compounds without prescriptions, creating legal risks. Additionally, international shipping requires specialized cold-chain logistics to maintain peptide stability, adding cost and complexity.
For most US users, purchasing from reputable domestic compounders remains the safest and often most cost-effective approach. Verify any international compounder\'s licensing, third-party testing, and sterilization standards before purchasing.
How to Find the Best Retatrutide Prices Safely
Finding low prices is easy; finding low prices from legitimate compounders is the challenge. Several red flags indicate unsafe or non-compliant operations.
Verifying Compounder Legitimacy
Before purchasing, verify:
- State pharmacy licensing: Check the state pharmacy board website for the compounder\'s current license status
- USP 797 compliance: Ask the compounder directly about USP 797 certification (this is standard for sterile injectable preparations)
- Third-party testing/COAs: Reputable compounders provide Certificates of Analysis from independent labs verifying peptide purity and sterility
- Physical address: Legitimate compounders have verifiable business addresses; avoid operations with only PO boxes
- Prescription requirement: Safe compounders require a valid prescription from a licensed provider
- Shipping practices: Proper temperature-controlled shipping with tracking for cold-chain maintenance
Red Flags for Unsafe Compounders
- Prices significantly lower than competitors ($250/10mg vial or less)
- No requirement for prescription or minimal verification
- No published third-party testing or certificates of analysis
- Aggressive social media marketing or MLM-style recruiting
- Vague about manufacturing standards or licensing
- No verifiable physical location or business registration
- Pressure to bulk-buy or use crypto payments
Questions to Ask Before Purchasing
Contact the compounder directly and ask:
- "What state pharmacy board do you operate under? Provide license number."
- "Are you USP 797 certified? Can you provide current certification?"
- "Do you provide third-party testing and COAs for each batch?"
- "What\'s your shipping method? How is cold chain maintained?"
- "What\'s your return/refund policy if product arrives damaged?"
- "How long have you been compounding retatrutide?" (Longer = more experience)
For additional information on pricing and cost factors, see our guides on retatrutide total cost of treatment, how to source retatrutide safely, and comparisons with compounded semaglutide and compounded tirzepatide. Check our semaglutide pricing guide for detailed pricing on alternatives.
Frequently Asked Questions
As of March 2026, compounded retatrutide typically ranges from $400-$700 per 10mg vial from reputable compounders, depending on vial size, purity testing, and sterility certifications. This translates to approximately $40-$70 per mg. Prices vary significantly based on compounder reputation and quality assurance.
At the 12mg maintenance dose (4 weekly injections of 3mg each), a month requires approximately 12mg total. A single 10mg vial covers most of the month, costing $400-$700. Many users purchase 2-3 vials monthly to ensure adequate stock, resulting in monthly costs of $800-$2,100 depending on pricing tier.
Yes, most reputable compounders offer volume discounts. Buying 3+ vials at once typically reduces the per-vial cost by 10-20%, and some compounders offer subscription pricing that discounts monthly auto-shipments by 15-25%. Always compare total cost, not just per-vial pricing, and verify the compounder's licensing.
Compounded tirzepatide costs $350-$600 per 10mg vial, and semaglutide costs $300-$500 per 5mg vial. On a per-mg basis: tirzepatide ≈ $35-$60/mg, semaglutide ≈ $60-$100/mg, and retatrutide ≈ $40-$70/mg. Retatrutide is mid-range, though pricing fluctuates monthly. Therapeutic outcomes differ: retatrutide shows superior weight loss (24.2% vs 15% for semaglutide).
Variation stems from: API sourcing costs, manufacturing overhead, sterility testing (USP standards cost more), licensure level (FDA-registered vs state-licensed), batch size, and business model. Established compounders with full USP testing cost more but provide greater safety assurance.
Check if the compounder is: (1) state-licensed pharmaceutical compounding facility, (2) USP 797 compliant, (3) offers third-party testing/COAs, (4) registered with state pharmacy boards. Compare prices across 3-5 reputable compounders; extreme low pricing may indicate quality corners. Avoid compounders with aggressive marketing or no verifiable licensing.
Most insurance plans do not cover compounded retatrutide since it's not FDA-approved and not on formularies. Once retatrutide gains FDA approval (likely 2026-2027), brand pricing will compete with compounded options, potentially driving down compounder prices. Currently, all compounded peptides are out-of-pocket expenses.